A detailed history of Corsicana & Co. transactions in Solid Biosciences Inc. stock. As of the latest transaction made, Corsicana & Co. holds 90 shares of SLDB stock, worth $436. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90
Previous 90 -0.0%
Holding current value
$436
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 05, 2022

SELL
$1.69 - $2.46 $6,760 - $9,840
-4,000 Reduced 97.8%
90 $1,000
Q2 2021

Jul 01, 2021

BUY
$3.49 - $5.51 $14,274 - $22,535
4,090 New
4,090 $15,000

Others Institutions Holding SLDB

# of Institutions
2
Shares Held
97
Call Options Held
0
Put Options Held
0

About Solid Biosciences Inc.


  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $36.5M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Corsicana & Co. Portfolio

Follow Corsicana & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corsicana & Co., based on Form 13F filings with the SEC.

News

Stay updated on Corsicana & Co. with notifications on news.